These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6191172)

  • 81. Advances in biological markers for cancer.
    Klavins JV
    Ann Clin Lab Sci; 1983; 13(4):275-80. PubMed ID: 6194735
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Early diagnosis of pancreatic cancer and carcinoembryonic antigen (CEO)].
    Culebras Fernandez JM
    Rev Esp Enferm Apar Dig; 1975 Dec; 46(6):645-56. PubMed ID: 1208960
    [No Abstract]   [Full Text] [Related]  

  • 83. [The significance of tumor-associated antigens in the diagnosis and therapeutic control of bronchial cancer].
    Gropp C; Luster W; Havemann K
    Prax Klin Pneumol; 1982 Dec; 36(12):491-9. PubMed ID: 7163127
    [No Abstract]   [Full Text] [Related]  

  • 84. Clinical evaluation of tissue polypeptide antigen (TPA) in the diagnosis of pancreatic carcinoma.
    Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttila I
    Anticancer Res; 1993; 13(5C):1883-7. PubMed ID: 8267397
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Early diagnosis of pancreatic cancer].
    Nakazawa S
    Gan No Rinsho; 1983 Aug; 29(10):1124-30. PubMed ID: 6195363
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Coproduction of carcinoembryonic antigen and nonspecific cross-reacting antigen by a continuous cell line from a human pancreatic tumor.
    Kuroki M; Ichiki S; Kuroki M; Matsuoka Y
    J Natl Cancer Inst; 1982 Aug; 69(2):401-8. PubMed ID: 6810002
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Recent progress in tumor markers of the digestive system].
    Mori T
    Gan No Rinsho; 1983 May; 29(6):663-71. PubMed ID: 6876437
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The diagnosis of exocrine pancreatic disease: the present position reviewed.
    Waller SL
    Aust N Z J Med; 1980 Jun; 10(3):351-62. PubMed ID: 6157384
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Fluid CEA in IPMNs: A useful test or the flip of a coin?
    Correa-Gallego C; Warshaw AL; Fernandez-del Castillo C
    Am J Gastroenterol; 2009 Mar; 104(3):796-7. PubMed ID: 19223886
    [No Abstract]   [Full Text] [Related]  

  • 90. Role of immunity in diagnosis of human cancer. Discussion.
    Br J Cancer Suppl; 1973 Aug; 1():237-42. PubMed ID: 4804284
    [No Abstract]   [Full Text] [Related]  

  • 91. [Hepatoid adenocarcinoma of the stomach. Case report and review of the literature].
    Antonini C; Forgiarini O; Chiara A; Briani G; Sacchi G
    Pathologica; 1997 Jun; 89(3):310-6. PubMed ID: 9380425
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Identification of pancreatic oncofetal antigen (POA) and its clinical significance].
    Nishida K; Yoshikawa T; Fukumoto K; Kondo M
    Rinsho Byori; 1982 Sep; Spec No 51():62-76. PubMed ID: 7176116
    [No Abstract]   [Full Text] [Related]  

  • 93. Recent advances in pancreatic cancer.
    Fortner JG
    Surg Clin North Am; 1974 Aug; 54(4):859-63. PubMed ID: 4610842
    [No Abstract]   [Full Text] [Related]  

  • 94. Immunology, tumor markers, and pancreatic cancer.
    Zamcheck N
    J Surg Oncol; 1975; 7(2):155-65. PubMed ID: 50499
    [No Abstract]   [Full Text] [Related]  

  • 95. [Early detection of pancreatic cancer by serum markers].
    Nakae Y; Naruse S; Shibata T; Kitagawa M; Kondo T; Hayakawa T; Kuno N; Kurimoto K
    Rinsho Byori; 1994 Feb; 42(2):139-42. PubMed ID: 7511183
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Detection of tumor cells in peritoneal lavages from patients with gastrointestinal cancer by multiplex reverse transcriptase PCR.
    Schmidt P; Thiele M; Rudroff C; Vaz A; Schilli M; Friedrich K; Scheele J
    Hepatogastroenterology; 2001; 48(42):1675-9. PubMed ID: 11813599
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A unique pancreatic tumor with exclusive hepatocytic differentiation.
    Shih NN; Tsung JS; Yang AH; Tsou MH; Cheng TY
    Ann Clin Lab Sci; 2006; 36(2):216-21. PubMed ID: 16682522
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Detection of serum tumor markers in the diagnosis and treatment of patients with pancreatic cancer.
    Jiang XT; Tao HQ; Zou SC
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):464-8. PubMed ID: 15313690
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Galactosyltransferase II: role in the diagnosis of pancreatic carcinoma.
    Podolsky DK; McPhee MS; Isselbacher KJ
    Trans Assoc Am Physicians; 1981; 94():21-9. PubMed ID: 6806961
    [No Abstract]   [Full Text] [Related]  

  • 100. Immunologic approaches to diagnosis of malignancy.
    Shuster J; Thomson DM; Fuks A; Gold P
    Prog Exp Tumor Res; 1980; 25():89-139. PubMed ID: 6153470
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.